The most prescribed IG
in the US
for
15 years1
(Based on combined data*)

*Internal calculations by Takeda based on Marketing Research Bureau (MRB)
database of total Ig Units prescribed over a combined 15 years (2005-2019).

GAMMAGARD LIQUID® is a ready-to-use liquid medicine that is given in a vein (intravenously)
or under the skin (subcutaneously) to treat primary immunodeficiency (PI) in people 2 years
and older, given in a vein to treat multifocal motor neuropathy (MMN) in adults,
and given in a vein to treat chronic inflammatory demyelinating polyneuropathy (CIDP) in adults.

Scroll to see more

GAMMAGARD LIQUID: an established IG with a long-standing history

Worldwide coverage icon.

120,108 patients

15 years of experience icon.

15 years of real-world
experience

IVIG bag icon.

1,441,300 infusions

Calculations based on units of GAMMAGARD LIQUID sold from 2006-2019, assuming an average utilization of 450 g/yr/patient.

Made with your needs in mind

Not all IVIGs are the same. GAMMAGARD LIQUID has a different formula.

Icon of no sugar.

No added sugars,
sucrose or glucose

Icon of no sodium.

No added
Sodium

Icon of no preservatives.

No added
preservatives

Icon of no glucose or proline stabilizers.

No proline
stabilizers

GAMMAGARD LIQUID is also stabilized and buffered with glycine.

Reference

  1. Marketing Research Bureau (MRB) database of total Ig Units prescribed over a combined 15 years (2005-2019).